Valuation: LivaNova PLC

Market Cap 4.21B 3.74B 3.5B 3.17B 5.99B 406B 6.03B 42.01B 16.34B 207B 15.81B 15.47B 666B P/E 2026 *
19.1x
P/E 2027 * 23x
Enterprise Value 4.29B 3.8B 3.56B 3.23B 6.09B 413B 6.14B 42.76B 16.63B 211B 16.09B 15.74B 678B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.53x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day-1.31%
1 week-1.94%
Current month-1.31%
1 month-6.44%
3 months-10.15%
6 months+18.90%
Current year+22.70%
1 week 74.23
Extreme 74.23
77.15
1 month 74.11
Extreme 74.11
81.83
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 2024-02-29
Director of Finance/CFO 56 2020-10-30
Investor Relations Contact - 2022-07-31
Director TitleAgeSince
Director/Board Member 69 2015-10-18
Chairman 74 2021-06-08
Director/Board Member 62 2019-06-17
Date Insider Type Main position Quantity % Market Cap. Importance
9/15/26 Free

General Counsel

6,291 0.0114%
9/10/26 Sell

Director

-3,500 0.0064%
9/4/26 Sell

Director

-2,300 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%-1.94%+43.45%+40.70% 4.21B
-1.69%-2.42%-26.35%+1.68% 173B
-1.47%-0.22%-11.72%+14.16% 113B
-1.94%+0.52%-23.50%+5.41% 109B
+1.52%+1.45%-46.87%-10.58% 74.44B
-0.13%+2.12%+2.89%+70.85% 60.1B
+3.27%+7.25%+18.14%+67.16% 51.87B
+0.44%-0.33%-5.53%-30.89% 49.21B
-2.13%-2.91%-17.50%+16.13% 41.52B
-3.67%-3.41%+26.11%+0.56% 32.79B
Average -0.71%+0.46%-4.09%+17.52% 70.93B
Weighted average by Cap. -0.83%+0.41%-15.21%+12.36%

Financials

2026 *2027 *
Net sales 1.52B 1.35B 1.26B 1.15B 2.16B 147B 2.18B 15.19B 5.91B 74.85B 5.71B 5.59B 241B 1.63B 1.45B 1.35B 1.23B 2.32B 157B 2.33B 16.26B 6.33B 80.17B 6.12B 5.99B 258B
Net income 226M 201M 188M 170M 322M 21.81B 324M 2.26B 878M 11.13B 849M 831M 35.77B 187M 166M 155M 141M 266M 18.02B 268M 1.86B 725M 9.19B 702M 687M 29.55B
Net Debt 75M 66.58M 62.3M 56.47M 107M 7.23B 107M 748M 291M 3.69B 282M 275M 11.86B -85M -75.45M -70.61M -64M -121M -8.19B -122M -848M -330M -4.18B -319M -312M -13.44B
Projected Income Statement - Annual - LivaNova PLC
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
26-10-06 US$75.40 -1.35% 153,644
26-10-05 US$76.43 +1.81% 558,947
26-10-02 US$75.07 +0.50% 528,517
26-10-01 US$74.70 -2.35% 767,262
26-09-30 US$76.50 -0.64% 970,700
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - LivaNova PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
76.43USD
Average target price
89.10USD
Spread / Average Target
+16.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LivaNova PLC
  1. Stock Market
  2. Stocks
  3. LIVN Stock